Outcome after PORT in ypN2 or R1/R2 versus no PORT in ypN0 Stage III-N2 NSCLC after Induction Chemotherapy and Resection
- 1 November 2016
- journal article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 11 (11) , 1940-1953
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non–Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)Journal of Clinical Oncology, 2015
- Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trialThe Lancet, 2015
- 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancerAnnals of Oncology, 2015
- Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 studyThe Lancet Oncology, 2015
- Corrigendum to “Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: A meta-analysis” [Radiother Oncol 110 (2014) 3–8]Radiotherapy and Oncology, 2014
- Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: A meta-analysisRadiotherapy and Oncology, 2014
- Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trialThe Lancet, 2009
- PROCLAIM: A Phase III Study of Pemetrexed, Cisplatin, and Radiation Therapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiation Therapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Locally Advanced Stage III Non–Small-Cell Lung Cancer of Other than Predominantly Squamous Cell HistologyClinical Lung Cancer, 2009
- Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II studyBritish Journal of Cancer, 2006
- Postoperative Adjuvant Therapy for Patients With Resected Non-Small Cell Lung Cancer: Still Controversial After all These YearsChest, 2000